For: | Ge WS, Wu JX, Fan JG, Wang YJ, Chen YW. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol 2011; 17(36): 4090-4098 [PMID: 22039322 DOI: 10.3748/wjg.v17.i36.4090] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i36/4090.htm |
Number | Citing Articles |
1 |
Hui Chen, Gang Li, Jianqiang Zhang, Ting Zheng, Qianglin Chen, Yanxiang Zhang, Fei Yang, Chao Wang, Hao Nie, Bing Zheng, Quan Gong. Sodium butyrate ameliorates Schistosoma japonicum-induced liver fibrosis by inhibiting HMGB1 expression. Experimental Parasitology 2021; 231: 108171 doi: 10.1016/j.exppara.2021.108171
|
2 |
Rui Kang, Ruochan Chen, Qiuhong Zhang, Wen Hou, Sha Wu, Lizhi Cao, Jin Huang, Yan Yu, Xue-gong Fan, Zhengwen Yan, Xiaofang Sun, Haichao Wang, Qingde Wang, Allan Tsung, Timothy R. Billiar, Herbert J. Zeh, Michael T. Lotze, Daolin Tang. HMGB1 in health and disease. Molecular Aspects of Medicine 2014; 40: 1 doi: 10.1016/j.mam.2014.05.001
|
3 |
Jian-Xing Luo, Yang Zhang, Xiao-Yu Hu, Guo Chen, Xi-Yun Liu, Hong-Ming Nie, Jing-Li Liu, Da-chao Wen. Aqueous extract from Aconitum carmichaelii Debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-ΚB/caspase-3 and PCNA signaling pathways. Journal of Ethnopharmacology 2016; 183: 187 doi: 10.1016/j.jep.2016.01.020
|
4 |
Haoye Zhang, Zhenguo Liu, Shikun Liu. HMGB1 induced inflammatory effect is blocked by CRISPLD2 via MiR155 in hepatic fibrogenesis. Molecular Immunology 2016; 69: 1 doi: 10.1016/j.molimm.2015.10.018
|
5 |
Neelam Lohani, Moganty R. Rajeswari. Antigene and Antiproliferative Effects of Triplex-Forming Oligonucleotide (TFO) Targeted on hmgb1 Gene in Human Hepatoma Cells. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(16): 1943 doi: 10.2174/1871520620666200619170438
|
6 |
Maite Duhalde Vega, José L. Aparício, Lilia A. Retegui. Levo-1-methyl tryptophan aggravates the effects of mouse hepatitis virus (MHV-A59) infection. International Immunopharmacology 2015; 24(2): 377 doi: 10.1016/j.intimp.2014.12.031
|
7 |
Chuan-tao Tu, Qun-yan Yao, Bei-li Xu, Ji-yao Wang, Chao-hui Zhou, Shun-cai Zhang. Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: Modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression. Food and Chemical Toxicology 2012; 50(9): 3343 doi: 10.1016/j.fct.2012.05.050
|
8 |
Ying-Hsien Kao, Yu-Chun Lin, Ming-Shian Tsai, Cheuk-Kwan Sun, Shyng-Shiou Yuan, Chih-Yang Chang, Bruno Jawan, Po-Huang Lee. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014; 1842(9): 1720 doi: 10.1016/j.bbadis.2014.06.017
|
9 |
Vahid Khanjarsim, Jamshid Karimi, Iraj Khodadadi, Adel Mohammadalipour, Mohammad Taghi Goodarzi, Ghasem Solgi, Mohammad Hashemnia. Ameliorative Effects of Nilotinib on CCl4 Induced Liver Fibrosis Via Attenuation of RAGE/HMGB1 Gene Expression and Oxidative Stress in Rat. Chonnam Medical Journal 2017; 53(2): 118 doi: 10.4068/cmj.2017.53.2.118
|
10 |
Jinfang Zhang, Hongwei Shen, Jiaojiao Xu, Li Liu, Jingwen Tan, Minghao Li, Nan Xu, Shenggen Luo, Jing Wang, Fan Yang, Jie Tang, Qinghua Li, Yiting Wang, Lei Yu, Zhiqiang Yan. Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities. ACS Nano 2020; 14(5): 6305 doi: 10.1021/acsnano.0c02633
|
11 |
Haoran Zhong, Xiang Gui, Ling Hou, Rongxue Lv, Yamei Jin. From Inflammation to Fibrosis: Novel Insights into the Roles of High Mobility Group Protein Box 1 in Schistosome-Induced Liver Damage. Pathogens 2022; 11(3): 289 doi: 10.3390/pathogens11030289
|
12 |
Liang Zhang, Yunxia Ji, Zechun Kang, Changjun Lv, Wanglin Jiang. Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway. Toxicology and Applied Pharmacology 2015; 283(1): 50 doi: 10.1016/j.taap.2015.01.001
|
13 |
Jianxing Luo, Yang Zhang, Xiaoyu Hu, Sen Zhong, Guo Chen, Yanyan Wang, Wu Lin, Cheng Yi, Hong Zhu. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by d-galactosamine in rats. Journal of Ethnopharmacology 2015; 161: 53 doi: 10.1016/j.jep.2014.12.003
|
14 |
Simona-Rebeca Ignat, Sorina Dinescu, Anca Hermenean, Marieta Costache. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development. Cells 2020; 9(2): 461 doi: 10.3390/cells9020461
|
15 |
Norma Maugeri, Patrizia Rovere-Querini, Mattia Baldini, Elena Baldissera, Maria Grazia Sabbadini, Marco E. Bianchi, Angelo A. Manfredi. Oxidative Stress Elicits Platelet/Leukocyte Inflammatory InteractionsviaHMGB1: A Candidate for Microvessel Injury in Sytemic Sclerosis. Antioxidants & Redox Signaling 2014; 20(7): 1060 doi: 10.1089/ars.2013.5298
|
16 |
Susan N. Christo, Kerrilyn R. Diener, Akash Bachhuka, Krasimir Vasilev, John D. Hayball. Innate Immunity and Biomaterials at the Nexus: Friends or Foes. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/342304
|
17 |
Tetsu Yamamoto, Yoshitsugu Tajima. HMGB1 is a promising therapeutic target for acute liver failure. Expert Review of Gastroenterology & Hepatology 2017; 11(7): 673 doi: 10.1080/17474124.2017.1345625
|
18 |
Liu‐Cheng Li, Jian Gao, Jun Li. Emerging role of HMGB1 in fibrotic diseases. Journal of Cellular and Molecular Medicine 2014; 18(12): 2331 doi: 10.1111/jcmm.12419
|
19 |
Toshiaki Kashiwadate, Shigehito Miyagi, Yasuyuki Hara, Yorihiro Akamatsu, Satoshi Sekiguchi, Naoki Kawagishi, Noriaki Ohuchi, Susumu Satomi. Soluble Thrombomodulin Ameliorates Ischemia-Reperfusion Injury of Liver Grafts by Modulating the Proinflammatory Role of High-Mobility Group Box 1. The Tohoku Journal of Experimental Medicine 2016; 239(4): 315 doi: 10.1620/tjem.239.315
|
20 |
Anna Alisi, Valerio Nobili, Sara Ceccarelli, Nadia Panera, Cristiano De Stefanis, Rita De Vito, Roberta Vitali, Giorgio Bedogni, Clara Balsano, Salvatore Cucchiara, Laura Stronati. Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease. Expert Review of Molecular Diagnostics 2014; 14(6): 763 doi: 10.1586/14737159.2014.928205
|
21 |
Shanfei Ge, Ying Xiong, Xiaoping Wu, Jianping Xie, Fei Liu, Jinni He, Tianxing Xiang, Na Cheng, Lingling Lai, Yuanbin Zhong. Role of growth factor receptor-bound 2 in CCl4-induced hepatic fibrosis. Biomedicine & Pharmacotherapy 2017; 92: 942 doi: 10.1016/j.biopha.2017.05.142
|
22 |
Zhi-Hua Xiao, Zheng-Yuan Xie, Qing Wang, Hui Lu, Heng-Wei Cao. SIRT7 affects autophagy and activation of hepatic stellate cells by regulating the acetylation level of high mobility group protein 1. Immunobiology 2023; 228(2): 152323 doi: 10.1016/j.imbio.2022.152323
|
23 |
Kyung Eun Kim, Keon-Hee Ko, Rok Won Heo, Chin-ok Yi, Hyun Joo Shin, Jun Young Kim, Jae-Ho Park, Sanghae Nam, Hwajin Kim, Gu Seob Roh. Artemisia annuaLeaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice. Journal of Medicinal Food 2016; 19(3): 290 doi: 10.1089/jmf.2015.3527
|
24 |
Walter Gottlieb Land. Damage-Associated Molecular Patterns in Human Diseases. 2018; : 845 doi: 10.1007/978-3-319-78655-1_36
|
25 |
Steffen K. Meurer, Morten A. Karsdal, Ralf Weiskirchen. Advances in the clinical use of collagen as biomarker of liver fibrosis. Expert Review of Molecular Diagnostics 2020; 20(9): 947 doi: 10.1080/14737159.2020.1814746
|
26 |
Shanfei Ge, Xiaoping Wu, Ying Xiong, Jianping Xie, Fei Liu, Wenfeng Zhang, Lixia Yang, Song Zhang, Lingling Lai, Jiansheng Huang, Ming Li, Yan-qing Yu. HMGB1 Inhibits HNF1A to Modulate Liver Fibrogenesis via p65/miR-146b Signaling. DNA and Cell Biology 2020; 39(9): 1711 doi: 10.1089/dna.2019.5330
|
27 |
Shuai Zhang, Zhecheng Wang, Jie Zhu, Ting Xu, Yan Zhao, Huanyu Zhao, Fan Tang, Zhenlu Li, Junjun Zhou, Dongyan Gao, Xiaofeng Tian, Jihong Yao. Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats. Frontiers in Pharmacology 2018; 8 doi: 10.3389/fphar.2017.00976
|
28 |
Kun Wang, Haotian Wei, Juan Zhan, Xinjun Liang, Chunxiu Zhang, Yanyan Liu, Gang Xu. GSPE alleviates renal fibrosis by inhibiting the activation of C3/ HMGB1/ TGF-β1 pathway. Chemico-Biological Interactions 2020; 316: 108926 doi: 10.1016/j.cbi.2019.108926
|
29 |
Siavash Bolourani, Max Brenner, Ping Wang. The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis. Journal of Molecular Medicine 2021; 99(10): 1373 doi: 10.1007/s00109-021-02113-y
|
30 |
Oluwaseun O. Ojo, Min Hyung Ryu, Aruni Jha, Helmut Unruh, Andrew J. Halayko. High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2015; 309(11): L1354 doi: 10.1152/ajplung.00054.2015
|
31 |
Ahmet Cagkan Inkaya, Nazlim Aktug Demir, Servet Kolgelier, Sua Sumer, Lutfi Saltuk Demir, Onur Ural, Fatma Seher Pehlivan, Mahmure Aslan, Abdullah Arpaci. Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?. Medicine 2017; 96(36): e7547 doi: 10.1097/MD.0000000000007547
|
32 |
Harriet Gaskell, Xiaodong Ge, Natalia Nieto. High‐Mobility Group Box‐1 and Liver Disease. Hepatology Communications 2018; 2(9): 1005 doi: 10.1002/hep4.1223
|
33 |
Wenwen Wang, Min Yan, Qiuhong Ji, Jinbiao Lu, Yuhua Ji, Juling Ji. Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-κB1. PeerJ 2015; 3: e1362 doi: 10.7717/peerj.1362
|
34 |
Rongzhen Jiang, Jingjing Cai, Zhaowei Zhu, Dandan Chen, Jiemei Wang, Qingde Wang, Yincheng Teng, Yajuan Huang, Minfang Tao, Aibin Xia, Min Xue, Shenghua Zhou, Alex F. Chen. Hypoxic Trophoblast HMGB1 Induces Endothelial Cell Hyperpermeability via the TRL-4/Caveolin-1 Pathway. The Journal of Immunology 2014; 193(10): 5000 doi: 10.4049/jimmunol.1303445
|
35 |
Ruochan Chen, Wen Hou, Qiuhong Zhang, Rui Kang, Xue-Gong Fan, Daolin Tang. Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases. Molecular Medicine 2013; 19(1): 357 doi: 10.2119/molmed.2013.00099
|